<DOC>
	<DOCNO>NCT00180505</DOCNO>
	<brief_summary>The purpose study investigate performance ABSOLUTE™ .035 peripheral self-expanding stent system prevent restenosis occlude stenotic superficial femoral proximal popliteal artery .</brief_summary>
	<brief_title>ASSESS Study : Evaluation ABSOLUTE™ Stent System Occluded Arteries</brief_title>
	<detailed_description>The treatment stenosis superficial femoral artery and/or proximal popliteal artery stenting associate high restenosis rate , especially first generation stent ( stainless steel ) . Currently , self-expandable nitinol stent commercialize lead high primary patency rate compare first generation stent , even long lesion . However , data available retrospective uni-center . The ASSESS study prospective multi-center study investigate performance ( restenosis rate , patency rate ) ABSOLUTE™ . 035 peripheral self-expandable stent long lesion ( lesion length 4.00 mm 200.00 mm ) . Moreover , literature show stent fracture nitinol stent , possible clinical relationship . For reason , ASSESS study analyze stent fracture ABSOLUTE™ stent , possible relationship stent fracture restenosis .</detailed_description>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>De novo lesion superficial femoral artery ( SFA ) proximal popliteal artery within follow parameter : 10 mm distal origin profunda femoris ( = 10 mm femoral bifurcation SFA ) 20 mm proximal margin intercondylar fossa . Patients must symptomatic leg ischemia , require treatment superficial femoral/proximal popliteal vessel Target vessel reference diameter visually estimate &gt; 4.0 mm &lt; 7.0 mm Target lesion length visually estimate &gt; 40 mm &lt; 200 mm If patient contralateral SFA contralateral proximal popliteal lesion , lesion treat nontarget lesion . The time way treatment nontarget lesion leave discretion investigator At least onevessel runoff foot confirm baseline angiography Patent common iliac artery , common femoral artery profunda confirm baseline angiography . The patent common iliac artery obtain index procedure successful treatment prior treatment target lesion . Successful treatment define attainment final residual diameter stenosis &lt; 30 % without death , stroke , bleed require &gt; 2 unit transfusion , complication device procedure relate . Patient acceptable candidate femoralpopliteal artery bypass surgery Previous ipsilateral femoropopliteal femorotibial surgery Presence stent target vessel Prescheduled staged procedure multiple lesion within ipsilateral iliac ipsilateral popliteal artery within 30 day index procedure Coexisting aneurysmal disease abdominal aorta iliac popliteal artery Acute thrombophlebitis deep vein thrombus Any immunosuppressive disorder , groin infection , acute systemic infection due cause viral bacterial infection Significant gastrointestinal ( GI ) bleed within past month would contraindicate use antiplatelet therapy Hemodynamic instability Target lesion restenotic previous intervention</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Peripheral Artery Disease</keyword>
	<keyword>Restenosis Rate</keyword>
	<keyword>Patency Rates</keyword>
	<keyword>Self-Expandable Nitinol Stents</keyword>
	<keyword>Stent Fractures</keyword>
</DOC>